1. Home
  2. TENX vs GIPR Comparison

TENX vs GIPR Comparison

Compare TENX & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • GIPR
  • Stock Information
  • Founded
  • TENX 1967
  • GIPR 2015
  • Country
  • TENX United States
  • GIPR United States
  • Employees
  • TENX N/A
  • GIPR N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • GIPR Real Estate Investment Trusts
  • Sector
  • TENX Health Care
  • GIPR Real Estate
  • Exchange
  • TENX Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • TENX 11.4M
  • GIPR 10.8M
  • IPO Year
  • TENX N/A
  • GIPR 2021
  • Fundamental
  • Price
  • TENX $3.79
  • GIPR $2.01
  • Analyst Decision
  • TENX Strong Buy
  • GIPR Hold
  • Analyst Count
  • TENX 3
  • GIPR 1
  • Target Price
  • TENX $23.00
  • GIPR N/A
  • AVG Volume (30 Days)
  • TENX 30.8K
  • GIPR 27.4K
  • Earning Date
  • TENX 11-11-2024
  • GIPR 11-12-2024
  • Dividend Yield
  • TENX N/A
  • GIPR 23.27%
  • EPS Growth
  • TENX N/A
  • GIPR N/A
  • EPS
  • TENX N/A
  • GIPR N/A
  • Revenue
  • TENX N/A
  • GIPR $9,659,091.00
  • Revenue This Year
  • TENX N/A
  • GIPR N/A
  • Revenue Next Year
  • TENX N/A
  • GIPR N/A
  • P/E Ratio
  • TENX N/A
  • GIPR N/A
  • Revenue Growth
  • TENX N/A
  • GIPR 74.44
  • 52 Week Low
  • TENX $2.77
  • GIPR $1.93
  • 52 Week High
  • TENX $61.20
  • GIPR $4.64
  • Technical
  • Relative Strength Index (RSI)
  • TENX 60.44
  • GIPR 37.62
  • Support Level
  • TENX $3.30
  • GIPR $1.98
  • Resistance Level
  • TENX $3.54
  • GIPR $2.10
  • Average True Range (ATR)
  • TENX 0.20
  • GIPR 0.09
  • MACD
  • TENX 0.03
  • GIPR 0.00
  • Stochastic Oscillator
  • TENX 77.14
  • GIPR 11.26

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in major markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: